Advertisement
Advertisement

CRVO

CRVO logo

CervoMed Inc. Common Stock

5.12
USD
Sponsored
-0.05
-0.99%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

5.13

+0.01
+0.12%

CRVO Earnings Reports

Positive Surprise Ratio

CRVO beat 14 of 29 last estimates.

48%

Next Report

Date of Next Report
Mar 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
$986.00K
/
-$0.63
Implied change from Q3 25 (Revenue/ EPS)
+205.67%
/
-25.00%
Implied change from Q4 24 (Revenue/ EPS)
-54.39%
/
-21.25%

CervoMed Inc. Common Stock earnings per share and revenue

On Nov 07, 2025, CRVO reported earnings of -0.84 USD per share (EPS) for Q3 25, missing the estimate of -0.78 USD, resulting in a -6.68% surprise. Revenue reached 322.57 thousand, compared to an expected 1.45 million, with a -77.68% difference. The market reacted with a -0.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.63 USD, with revenue projected to reach 986.00 thousand USD, implying an decrease of -25.00% EPS, and increase of 205.67% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, CervoMed Inc. Common Stock reported EPS of -$0.84, missing estimates by -6.68%, and revenue of $322.57K, -77.68% below expectations.
The stock price moved down -0.29%, changed from $6.92 before the earnings release to $6.90 the day after.
The next earning report is scheduled for Mar 16, 2026.
Based on 9 analysts, CervoMed Inc. Common Stock is expected to report EPS of -$0.63 and revenue of $986.00K for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement